Alaunos Therapeutics Inc. (TCRT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alaunos Therapeutics Inc.

    NASDAQ: TCRT · Real-Time Price · USD
    2.10
    -0.06 (-2.78%)
    At close: Sep 05, 2025, 11:39 AM

    Alaunos Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 10K 5K 2.92M 398K
    Cost of Revenue
    		 n/a 4.8M 2.76M 740K
    Gross Profit
    		 10K -4.8M 163K -342K
    Operating Income
    		 -4.81M -34.27M -35.1M -77.55M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -4.68M -35.14M -37.73M -78.75M
    Net Income
    		 -4.68M -35.14M -37.6M -76.89M
    Selling & General & Admin
    		 4.46M 12.22M 13.14M 27.56M
    Research & Development
    		 362K 16.28M 25.02M 49.64M
    Other Expenses
    		 n/a 971K 529K n/a
    Operating Expenses
    		 4.82M 29.47M 38.16M 77.21M
    Interest Expense
    		 n/a 1.92M 3.15M 1.18M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 4.82M 34.27M 38.16M 77.21M
    Income Tax Expense
    		 n/a n/a -133K -1.86M
    Shares Outstanding (Basic)
    		 1.6M 1.6M 1.45M 1.43M
    Shares Outstanding (Diluted)
    		 1.6M 1.6M 1.45M 1.43M
    EPS (Basic)
    		 -2.92 -21.97 -25.97 -53.8
    EPS (Diluted)
    		 -2.92 -21.97 -25.97 -53.8
    EBITDA
    		 -4.68M -30.9M -31.82M -74.97M
    EBIT
    		 -4.68M -33.22M -34.58M -77.56M
    Depreciation & Amortization
    		 2K 2.31M 2.76M 2.6M

    Add to Watchlist